Clinical Hub for Interventional Research (CHOIR), College of Health and Medicine, The Australian National University Acton, Canberra, Australia.
Department of Clinical Haematology, Canberra Region Cancer Centre, The Canberra Hospital Garran, Canberra, Australia.
Br J Haematol. 2023 Feb;200(4):401-403. doi: 10.1111/bjh.18546. Epub 2022 Nov 17.
Human herpesvirus 8 (HHV-8), also called Kaposi sarcoma herspesvirus (KSHV), causes several human tumours, which may be associated with systemic inflammation and body cavity effusions, including a form of multicentric Castleman disease (MCD) and a novel inflammatory syndrome, KSHV inflammatory cytokine syndrome (KICS). In this issue, Zhou et al. demonstrate that HHV-8-infected lambda-restricted plasmablasts can be detected in these effusions and can be used to distinguish MCD from other HHV-8 tumours as well as to categorise KICS into distinct clinicopathological groups. These findings open a path to an integrated clinicopathological approach to HHV-8-associated inflammatory diseases and may have clinical implications. Commentary on: Zhou et al. A novel approach for characterisation of KSHV-associated multicentric Castleman disease from effusions. Br J Haematol 2023;200:462-475.
人类疱疹病毒 8 型(HHV-8),也称为卡波济肉瘤疱疹病毒(KSHV),可引起多种人类肿瘤,这些肿瘤可能与全身炎症和体腔渗出物有关,包括一种多中心 Castleman 病(MCD)和一种新型炎症综合征,即 KSHV 炎症细胞因子综合征(KICS)。在本期中,Zhou 等人表明,这些渗出物中可以检测到感染 HHV-8 的限制性 lambda 浆细胞,并可用于区分 MCD 与其他 HHV-8 肿瘤,以及将 KICS 分类为不同的临床病理组。这些发现为 HHV-8 相关炎症性疾病的综合临床病理方法开辟了道路,并可能具有临床意义。述评:Zhou 等人。从渗出液中鉴定 KSHV 相关多中心 Castleman 病的新方法。英国血液学杂志 2023;200:462-475。